AIM-HI draws startups from the deep pipeline of National Foundation for Cancer Research (NFCR) funded scientists and the best-in-class global scientist-entrepreneur community.
Every year, hundreds of innovations and discoveries take place in research labs, academia, and leading cancer centers around the world. Surprisingly, only a small percentage ever make it into commercial ventures. The traditional commercialization approach facilitated by university technology transfer offices have met meager outcomes.
Our Approach
AIM-HI sources deals from a deep pipeline. We leverage our relationships with NFCR and the Asian Foundation for Cancer Research to curate the best entrepreneurial projects, including those participating in and uncovered by their Salisbury Award for Entrepreneurial Translational Research and Bridging Research from Academia to Cancer Entrepreneurship (BRACE) Award programs.
AIM-HI’s venture accelerator approach helps the scientist-entrepreneur focus on the technology while partnering with them to provide the necessary business, financial, legal and infrastructure support from the entrepreneurial ecosystem.
AIM-HI has invested in the following outstanding startups, made up of scientist-entrepreneurs and their brilliant ideas with commercial potential. Please click on each company to read more of their story.
